Showing 81-100 of 387 for: Cochrane Systematic Reviews > Gynecologic 
- Combined use of hyperthermia and (chemo)radiation therapy for treating locally advanced cervix carcinoma
Cochrane Systematic Reviews, 17-Mar-2010
Hyperthermia is a type of cancer treatment in which body tissue is exposed to high temperatures to damage and kill cancer cells. It was introduced into clinical oncology practice several decades ago. Positive clinical results, mostly obtained in single in
- Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix
Cochrane Systematic Reviews, 20-Jul-2005
The National Cancer Institute (USA) alert in February 1999 stated that concomitant chemoradiotherapy should be considered for all patients with cervical cancer, based on evidence from five randomised controlled trials (RCTs).
- Concomitant hydroxyurea plus radiotherapy versus radiotherapy for carcinoma of the uterine cervix
Cochrane Systematic Reviews, 26-Jan-2004
A number of randomised studies suggest hydroxyurea given alongside radiotherapy improves survival in patients with locally advanced cervix cancer. Following publication of five large randomised trials in 1999 and 2000 concomitant chemoradiotherapy has bec
- Conservative prevention and management of pelvic organ prolapse in women
Cochrane Systematic Reviews, 10-Nov-2011
Pelvic organ prolapse is common, and some degree of prolapse is seen in 50% of parous women. Women with prolapse can experience a variety of pelvic floor symptoms. Treatments include surgery, mechanical devices and conservative management. Conservative ma
- Continuous and interrupted suturing techniques for repair of episiotomy or second‐degree tears
Cochrane Systematic Reviews, 14-Nov-2012
Millions of women worldwide undergo perineal suturing after childbirth and the type of repair may have an impact on pain and healing. For more than 70 years, researchers have been suggesting that continuous non-locking suture techniques for repair of the
- Continuous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraception
Cochrane Systematic Reviews, 29-Jul-2014
The avoidance of menstruation through continuous or extended (greater than 28 days) administration of combination hormonal contraceptives (CHCs) has gained legitimacy through its use in treating endometriosis, dysmenorrhea, and menstruation-associated sym
- Copper containing intra-uterine devices versus depot progestogens for contraception
Cochrane Systematic Reviews, 9-Aug-2011
Highly effective contraception is essential to reduce unintended pregnancies and the effect these have on individuals, society and public health resources. Intrauterine devices (IUDs) and depot progestogens are two commonly used long-acting, reversible co
- Copper containing, framed intra-uterine devices for contraception
Cochrane Systematic Reviews, 8-Jun-2008
Intrauterine devices (IUD) are safe and effective methods of long term reversible contraception. The design, and copper content as well as placement of the copper on IUDs could affect their effectiveness and side-effect profile.
- Corticosteroids for the resolution of malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer
Cochrane Systematic Reviews, 24-Jan-2000
This is an update of the review published in Issue 3, 1999. Gastrointestinal and ovarian cancers are common cancers. The incidence of associated malignant bowel obstruction in patients with advanced cancers of these types is not known, and the best manage
- Cycle regimens for frozen‐thawed embryo transfer
Cochrane Systematic Reviews, 5-Jul-2017
Among subfertile couples undergoing assisted reproductive technology (ART), pregnancy rates following frozen-thawed embryo transfer (FET) treatment cycles have historically been found to be lower than following embryo transfer undertaken two to five days
- Cyclical progestogens for heavy menstrual bleeding
Cochrane Systematic Reviews, 14-Aug-2019
Heavy menstrual bleeding (HMB) is a menstrual blood loss perceived by women as excessive that affects the health of women of reproductive age, interfering with their physical, emotional, social and material quality of life. Whilst abnormal menstrual bleed
- Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer
Cochrane Systematic Reviews, 16-Jun-2010
Most women with advanced epithelial ovarian cancer will ultimately develop recurrent disease after completion of initial treatment with primary surgery and adjuvant chemotherapy. Secondary cytoreductive surgery may have survival benefits in selected patie
- Danazol for heavy menstrual bleeding
Cochrane Systematic Reviews, 18-Jul-2007
Heavy menstrual bleeding (HMB) is an important cause of ill health in pre menopausal women. Medical therapy, with the avoidance of possibly unnecessary surgery is an attractive treatment option, but there is considerable variation in practice and uncertai
- Danazol for pelvic pain associated with endometriosis
Cochrane Systematic Reviews, 20-Sep-2010
Endometriosis is defined as the presence of endometrial tissue (stromal and glandular) outside the normal uterine cavity. Conventional medical and surgical treatments for endometriosis aim to remove or decrease the deposits of ectopic endometrium. The obs
- Danazol for unexplained subfertility
Cochrane Systematic Reviews, 9-Nov-2008
The synthetic androgen Danazol, was developed in the 1970's as a treatment for endometriosis. Its use was soon advocated in women with unexplained subfertility. Two randomised trials were subsequently conducted to assess the effectiveness of danazol in th
- Danazol for uterine fibroids
Cochrane Systematic Reviews, 8-Jul-2009
Uterine fibroids (myomas, fibromyomas, leiomyomas) are the most common benign tumours of the female genital tract. Danazol, a synthetic isoxazole derivative chemically related to 17-ethinyl testosterone, has been used for many years for the treatment of w
- Day three versus day two embryo transfer following in vitro fertilization or intracytoplasmic sperm injection
Cochrane Systematic Reviews, 14-Dec-2016
Embryo transfer (ET) was traditionally performed two days after oocyte retrieval; however, developments in culture media have allowed embryos to be maintained in culture for longer periods. Delaying transfer from Day two to Day three would allow for furth
- Depot medroxyprogesterone versus Norethisterone oenanthate for long-acting progestogenic contraception.
Cochrane Systematic Reviews, 7-Mar-2012
There are two injectable progestogen-only contraceptives (IPCs) that have been available in many countries in the world since 1983. They are both still extensively used in many developing countries, forming a large proportion of the health system's expend
- Depot versus daily administration of gonadotrophin‐releasing hormone agonist protocols for pituitary down regulation in assisted reproduction cycles
Cochrane Systematic Reviews, 31-Jan-2013
Gonadotrophin-releasing hormone agonist (GnRHa) is commonly used to switch off (down regulate) the pituitary gland and thus suppress ovarian activity in women undergoing in vitro fertilisation (IVF). Other fertility drugs (gonadotrophins) are then used to
- Diaphragm versus diaphragm with spermicides for contraception
Cochrane Systematic Reviews, 20-Jan-2003
The diaphragm is usually used with a spermicide. However, some practitioners have suggested that spermicides offer no additional contraceptive protection and have advocated alternative guidelines for the use of diaphragms.
